Jean-charles C. Vallee-Duclos

Villejuif, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 113 publications

Long-term remission of azathioprine and steroid-resistant type I autoimmune hepatitis with ursodesoxycholic acid.

Long-term remission of azathioprine and steroid-resistant type I autoimmune hepatitis with ursodesoxycholic acid.

Journal: Clinics and research in hepatology and gastroenterology

Published: August 05, 2026

In vitro space of Disse model for exploration of drug induced hepatotoxicity.

In vitro space of Disse model for exploration of drug induced hepatotoxicity.

Journal: Lab on a chip

Published: March 25, 2026

Liver organoids: from promise to functional complexity

Liver organoids: from promise to functional complexity

Journal: Medecine sciences : M/S

Published: March 20, 2026

Analysis of the Mitochondrial Dynamics in NAFLD: Drp1 as a Marker of Inflammation and Fibrosis.

Analysis of the Mitochondrial Dynamics in NAFLD: Drp1 as a Marker of Inflammation and Fibrosis.

Journal: International journal of molecular sciences

Published: June 19, 2025

Stem Cells and Organoids: A Paradigm Shift in Preclinical Models Toward Personalized Medicine.

Stem Cells and Organoids: A Paradigm Shift in Preclinical Models Toward Personalized Medicine.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: June 06, 2025

Community-based versus facility-based services to improve hepatitis C screening in Cambodia: a cluster randomized controlled trial (ANRS 12384 Cam-C study).

Community-based versus facility-based services to improve hepatitis C screening in Cambodia: a cluster randomized controlled trial (ANRS 12384 Cam-C study).

Journal: The Lancet regional health. Western Pacific

Published: June 06, 2025

Features and Outcomes of 280 Patients With Idiosyncratic Drug-Induced Liver Injury: The REFHEPS Prospective Study.

Features and Outcomes of 280 Patients With Idiosyncratic Drug-Induced Liver Injury: The REFHEPS Prospective Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 04, 2025

Hepatic organoids as a platform for liver disease modeling and the development of novel therapies.

Hepatic organoids as a platform for liver disease modeling and the development of novel therapies.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 02, 2025

Whole Exome Sequencing in Children With Autoimmune Hepatitis Identified Mutations in Genes Involved in the mTORC1 Signaling Pathway.

Whole Exome Sequencing in Children With Autoimmune Hepatitis Identified Mutations in Genes Involved in the mTORC1 Signaling Pathway.

Journal: Gastro hep advances

Published: April 04, 2025

Autoimmune Features in Sickle Cell Patients: A New Explanation for Liver Damage?

Autoimmune Features in Sickle Cell Patients: A New Explanation for Liver Damage?

Journal: American journal of hematology

Published: April 03, 2025

State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment.

Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Published: December 21, 2024

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.

Journal: Journal of hepatology

Published: July 02, 2024

Showing 1-12 of 113

Last Updated: 09/26/2026